EVALUATION OF EARLY OUTCOMES OF MINIMALLY INVASIVE ATRIAL SEPTAL DEFECT CLOSURE THROUGH RIGHT THORACOTOMY IN ADULTS
Main Article Content
Abstract
Objective: To evaluate the safety and efficacy of minimally invasive atrial septal defect (ASD) closure through right thoracotomy in adults. Methods: A retrospective descriptive case series. Results: from May 2022 to June 2024, there were 44 patients (17 males, 27 females) who underwent minimally invasive ASD closure through a right thoracotomy at Cho Ray hospital. The mean age was 37,1 ± 10,8 years (range 19 – 65). Of the 44 patients, 38 (86,4%), 3 (6,8%), 2 (4,6%), and 1 (2,3%) had secundum ASD, primum ASD, superior sinus venosus ASD, and inferior sinus venosus ASD, respectively. Abnormal pulmonary venous return was recorded in 2 cases (4,6%). Concomitant cardiac defect repair surgery was performed in 29 cases (65,9%). No in-hospital mortality was recorded. The cardiopulmonary bypass time was 73 ± 28 minutes (range 25 – 130), and the surgery time averaged 163 ± 42 minutes (range 80 – 250). Mechanical ventilation time was 9,2 ± 3,9 hours (range 3,5–17,3), ICU stay was 34,7 ± 24,2 hours (range 15,5 – 116), and postoperative hospital stay was 8 ± 4 days (range 4–21). No residual shunts were recorded after surgery. Major complications: Two patients (4,6%) required permanent pacemaker implantation. Minor complications: Six patients (13,7%) had pneumothorax, and 8 patients (18,2%) developed pneumonia requiring antibiotic treatment. No patients required reoperation for bleeding control or had wound infections. Conclusion: Minimally invasive ASD closure through right thoracotomy in adults had proven to be highly safe and effective.
Article Details
Keywords
Atrial septal defect, minimally invasive cardiac surgery
References
2. Silvestry FE, Cohen MS, Armsby LB, et al. Guidelines for the Echocardiographic Assessment of Atrial Septal Defect and Patent Foramen Ovale: From the American Society of Echocardiography and Society for Cardiac Angiography and Interventions. J Am Soc Echocardiogr. Aug 2015; 28(8):910-58. doi:10.1016/j.echo.2015.05.015
3. Zhu J, Zhang Y, Bao C, Ding F, Mei J. Individualized strategy of minimally invasive cardiac surgery in congenital cardiac septal defects. Journal of Cardiothoracic Surgery. 01/15 2022;17doi:10.1186/s13019-022-01753-6
4. Turner DR, Owada CY, Sang CJ, Jr., Khan M, Lim DS. Closure of Secundum Atrial Septal Defects With the AMPLATZER Septal Occluder: A Prospective, Multicenter, Post-Approval Study. Circ Cardiovasc Interv. Aug 2017;10(8):e004212. doi:10.1161/circinterventions.116.004212
5. Lei Y-Q, Liu J-F, Xie W-P, Hong Z-N, Chen Q, Cao H. Anterolateral minithoracotomy versus median sternotomy for the surgical treatment of atrial septal defects: a meta-analysis and systematic review. Journal of Cardiothoracic Surgery. 2021/09/20 2021;16(1):266. doi:10.1186/ s13019-021-01648-y
6. Yanagisawa J, Maekawa A, Sawaki S, et al. Three-port totally endoscopic repair vs conventional median sternotomy for atrial septal defect. Surg Today. Feb 2019;49(2):118-123. doi:10.1007/s00595-018-1713-0
7. Tang Y, Wu Y, Zhu J, et al. Total endoscopic repair of atrial septal defect under on-pump beating heart. J Thorac Dis. Dec 2018;10(12): 6557-6562. doi:10.21037/jtd.2018.10.89
8. Schneeberger Y, Schaefer A, Conradi L, et al. Minimally invasive endoscopic surgery versus catheter-based device occlusion for atrial septal defects in adults: reconsideration of the standard of care. Interact Cardiovasc Thorac Surg. Apr 1 2017;24(4):603-608. doi:10.1093/icvts/ivw366